Stationary robot in stroke rehabilitatio

Not Applicable

• Conditions: Stroke; Circulatory System; Stroke, not specified as haemorrhage or infarction

• Registration Number: ISRCTN50278774
• Lead Sponsor: Akademii Wychowania Fizycznego im. Jerzego Kukuczki w Katowicach

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2022-03-14
• Last Update Posted: 28 March 2022
• Study Completion: 2022-06-30

Recruitment & Eligibility

• Status: Ongoing
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

1. Women and men over 18 years of age
2. First history of ischemic or hemorrhagic brain
3. The period min. 1 month after stroke
4. The patient's consent to participate in the study
5. Ability to understand and follow the therapist's instructions
6. Ability to walk independently on a distance of 10 meters (it is allowed to use supporting tools, such as a walking stick, a ball or a walking frame)

Exclusion Criteria

1. Contraindications to exercises in the study
2. Subarachnoid hemorrhage
3. Neurological diseases other than stroke affecting body balance and quality of the gait
5. Body structure, articular stiffness and other dysfunctions that are contraindicators to therapy in a stationary gait rehabilitation robot (mainly: body weight over 95 kg, body height below 150 cm and over 199 cm, difference in the length of the lower limbs over 1.5 cm, spasticity over the 3rd degree in Ashworth scale, wounds on the body at fixation sites on stationary rehabilitation robot)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Gait assessed by 10 Metre Walk Test (10MWT), at baseline and after the 3-week rehabilitation period<br> 2. Gait assessed by treadmill walking test (Zebris FDM-T; Rehawalk, MaxxusDaum h/p Cosmos Force) at baseline and after the 3-week rehabilitation period<br> 3. Spatial and temporal gait parameters assessed using the 3D MyoMotion device (Noraxon, USA) at baseline and after the 3-week rehabilitation period<br>

Secondary Outcome Measures

Name	Time	Method
<br> 1. Static and dynamic body balance assessed by Berg Balance Scale (BBS) at baseline and after the 3-week rehabilitation period<br> 2. Dynamic body balance assessed by Time Up and Go Test (TUG) at baseline and after the 3-week rehabilitation period<br> 3. Dynamic body balance assessed by Functional Reach Test (FRT) at baseline and after the 3-week rehabilitation period<br> 4. Static body balance assessed by stabilometric platform (Zebris FDM-T; Rehawalk, MaxxusDaum h/p Cosmos Force) at baseline and after the 3-week rehabilitation period<br> 5. Quality of life assessed with Stroke Impact Scale (SIS - 59) at baseline and after the 3-week rehabilitation period<br> 6. ADL assessed with Barthel Scale at baseline and after the 3-week rehabilitation period<br>